Arteriovenous access failure: More than just intimal hyperplasia?

Nephrology Dialysis Transplantation

Volumn 28, Issue 5, 2013, Pages 1085-1092

  Rothuizen, Tonia C ^a   Wong, Chunyu ^a   Quax, Paul H A ^a   Van Zonneveld, Anton Jan ^a   Rabelink, Ton J ^a   Rotmans, Joris I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

arteriovenous fistula; haemodialysis access; intimal hyperplasia; outward remodelling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CATHEPSIN; CYTOKINE; ELASTASE; ENDOTHELIN; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR; RAPAMYCIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL REACTIVITY; CELL DEDIFFERENTIATION; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEMODIALYSIS PATIENT; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENOVASCULAR DISEASE; VASCULAR ACCESS; VASCULAR PATENCY; VASCULAR SURGERY;

ARTERIOVENOUS FISTULA; HAEMODIALYSIS ACCESS; INTIMAL HYPERPLASIA; OUTWARD REMODELLING;

ANIMALS; ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; HYPERPLASIA; TUNICA INTIMA; VASCULAR PATENCY;

EID: 84877955844     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft068     Document Type: Article

References (80)

1. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemo-dialysis patients: problems and solutions. Kidney Int 2002; 62: 1109-1124
2. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(Suppl 1): S248-S273
3. Gibson KD, Gillen DL, Caps MT et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694-700
4. Tordoir JH, Rooyens P, Dammers R et al. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for hae-modialysis. Nephrol Dial Transplant 2003; 18: 378-383
5. Roy-Chaudhury P, Spergel LM, Besarab A et al. Biology of arter-iovenous fistula failure. J Nephrol 2007; 20: 150-163
6. Dember LM, Beck GJ, Allon M et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299: 2164-2171
7. Lazarides MK, Georgiadis GS, Antoniou GA et al. A meta-analy-sis of dialysis access outcome in elderly patients. J Vasc Surg 2007; 45: 420-426
8. Saucy F, Haesler E, Haller C et al. Is intra-operative blood flow predictive for early failure of radiocephalic arteriovenous fistula? Nephrol Dial Transplant 2010; 25: 862-867
9. Cooke JP, Rossitch E, Jr, Andon NA et al. Flow activates an endo-thelial potassium channel to release an endogenous nitrovasodi-lator. J Clin Invest 1991; 88: 1663-1671
10. Tronc F, Wassef M, Esposito B et al. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 1996; 16: 1256-1262
11. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012
12. Corpataux JM, Haesler E, Silacci P et al. Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant 2002; 17: 1057-1062
13. Ene-Iordache B, Mosconi L, Antiga L et al. Radial artery remodeling in response to shear stress increase within arteriovenous fistula for hemodialysis access. Endothelium 2003; 10: 95-102
14. Girerd X, London G, Boutouyrie P et al. Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension 1996; 27: 799-803
15. Chan CY, Chen YS, Ma MC et al. Remodeling of experimental ar-teriovenous fistula with increased matrix metalloproteinase expression in rats. J Vasc Surg 2007; 45: 804-811
16. Langer S, Heiss C, Paulus N et al. Functional and structural response of arterialized femoral veins in a rodent AV fistula model. Nephrol Dial Transplant 2009; 24: 2201-2206
17. Garanich JS, Pahakis M, Tarbell JM. Shear stress inhibits smooth muscle cell migration via nitric oxide-mediated downregulation of matrix metalloproteinase-2 activity. Am J Physiol Heart Circ Physiol 2005; 288: H2244-H2252
18. Frangos JA, Eskin SG, McIntire LV et al. Flow effects on prostacy-clin production by cultured human endothelial cells. Science 1985; 227: 1477-1479
19. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438
20. Lee ES, Shen Q, Pitts RL et al. Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation. J Vasc Surg 2011; 54: 454-459
21. Tronc F, Mallat Z, Lehoux S et al. Role of matrix metalloprotei-nases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 2000; 20: E120-E126
22. Chang CJ, Chen CC, Hsu LA et al. Degradation of the internal elastic laminae in vein grafts of rats with aortocaval fistulae: potential impact on graft vasculopathy. Am J Pathol 2009; 174: 1837-1846
23. De Mey JG, Schiffers PM, Hilgers RH et al. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol 2005; 288: H1022-H1027
24. Nassar GM, Nguyen B, Rhee E et al. Endovascular treatment of the 'failing to mature' arteriovenous fistula. Clin J Am Soc Nephrol 2006; 1: 275-280
25. Sivanesan S, How TV, Bakran A. Sites of stenosis in AV fistulae for haemodialysis access. Nephrol Dial Transplant 1999; 14: 118-120
26. Rotmans JI, Pasterkamp G, Verhagen HJ et al. Hemodialysis access graft failure: time to revisit an unmet clinical need? J Nephrol 2005; 18: 9-20
27. Weiss MF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001; 37: 970-980
28. Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 2009; 16: 329-338
29. Roy-Chaudhury P, Wang Y, Krishnamoorthy M et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 2009; 24: 2786-2791
30. Li L, Terry CM, Blumenthal DK et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 2007; 22: 3139-3146
31. Tang Z, Wang A, Yuan F et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun 2012; 3: 875
32. Diao Y, Guthrie S, Xia SL et al. Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol 2008; 172: 839-848
33. Caplice NM, Wang S, Tracz M et al. Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol 2007; 293: F470-F475
34. Owens CD. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg 2010; 51: 736-746
35. Ene-Iordache B, Remuzzi A. Disturbed flow in radial-cephalic arteriovenous fistulae for haemodialysis: low and oscillating shear stress locates the sites of stenosis. Nephrol Dial Transplant 2012; 27: 358-368
36. Ene-Iordache B, Cattaneo L, Dubini G et al. Effect of anastomosis angle on the localization of disturbed flow in 'side-to-end' fistulae for haemodialysis access. Nephrol Dial Transplant 2012
37. Krishnamoorthy MK, Banerjee RK, Wang Y et al. Hemodynamic wall shear stress profiles influence the magnitude and pattern of stenosis in a pig AV fistula. Kidney Int 2008; 74: 1410-1419
38. Lee T, Chauhan V, Krishnamoorthy M et al. Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant 2011; 26: 2264-2270
39. Friedl R, Li J, Schumacher B et al. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery. Ann Thorac Surg 2004; 78: 1312-1318
40. Ernandez T, Saudan P, Berney T et al. Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract 2005; 101: c39-c44
41. Lok CE, Allon M, Moist L et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arter-iovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17: 3204-3212
42. Monroy-Cuadros M, Yilmaz S, Salazar-Banuelos A et al. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol 2010; 5: 1787-1792
43. Heine GH, Ulrich C, Sester U et al. Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int 2003; 64: 1101-1107
44. Lin CC, Yang WC, Lin SJ et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006; 69: 165-172
45. Tummers AM, Mountain DJ, Mix JW et al. Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia. J Surg Res 2010; 160: 9-13
46. Misra S, Fu AA, Anderson JL et al. The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and-9 at the venous stenosis. J Vasc Interv Radiol 2008; 19: 587-594
47. Cheng XW, Kuzuya M, Sasaki T et al. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointi-ma of balloon-injured rat carotid arteries. Am J Pathol 2004; 164: 243-251
48. Abeles D, Kwei S, Stavrakis G et al. Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg 2006; 44: 863-870
49. Amabile PG, Wong H, Uy M et al. In vivo vascular engineering of vein grafts: directed migration of smooth muscle cells by peri-vascular release of elastase limits neointimal proliferation. J Vasc Interv Radiol 2002; 13: 709-715
50. Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 2002; 277: 44854-44863
51. Reddel CJ, Weiss AS, Burgess JK. Elastin in asthma. Pulm Pharmacol Ther 2012; 25: 144-153
52. Palmes D, Kebschull L, Schaefer RM et al. Perforating vein fistula is superior to forearm fistula in elderly haemodialysis patients with diabetes and arterial hypertension. Nephrol Dial Transplant 2011; 26: 3309-3314
53. Konner K, Hulbert-Shearon TE, Roys EC et al. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62: 329-338
54. Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
55. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
56. Brunet P, Gondouin B, Duval-Sabatier A et al. Does uremia cause vascular dysfunction? Kidney Blood Press Res 2011; 34: 284-290
57. Gunthner T, Jankowski V, Kretschmer A et al. Endothelium and vascular smooth muscle cells in the context of uremia. Semin Dial 2009; 22: 428-432
58. Moody WE, Edwards NC, Madhani M et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis 2012; 223: 86-94
59. Kokubo T, Ishikawa N, Uchida H et al. CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 2009; 20: 1236-1245
60. Wali MA, Eid RA, Dewan M et al. Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. Ann Thorac Cardio-vasc Surg 2006; 12: 341-348
61. Wasse H, Huang R, Naqvi N et al. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access 2012; 13: 168-174
62. O'Neill WC, Lomashvili KA. Recent progress in the treatment of vascular calcification. Kidney Int 2010; 78: 1232-1239
63. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
64. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021
65. Huang PH, Chen LC, Leu HB et al. Enhanced coronary calcification determined by electron beam CT is strongly related to endo-thelial dysfunction in patients with suspected coronary artery disease. Chest 2005; 128: 810-815
66. Lee T, Safdar N, Mistry MJ et al. Preexisting venous calcification prior to dialysis vascular access surgery. Semin Dial 2012; 25: 592-595
67. van der Linden J, Lameris TW, van den Meiracker AH et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47: 1013-1019
68. Allon M, Litovsky S, Young CJ et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis 2011; 58: 437-443
69. Tordoir J, Canaud B, Haage P et al. EBPG on Vascular Access. Nephrol Dial Transplant 2007; 22(Suppl 2): ii88-i117
70. Chang CJ, Ko PJ, Hsu LA et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis 2004; 43: 74-84
71. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 1992; 42: 1390-1397
72. Lee T, Ullah A, Allon M et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol 2011; 6: 575-581
73. Peden EK, Leeser DB, Dixon BS et al. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access 2012; 0: 0
74. Pai AS, Giachelli CM. Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol 2010; 21: 1637-1640
75. Paulson WD, Kipshidze N, Kipiani K et al. Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodia-lysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R). Nephrol Dial Transplant 2012; 27: 1219-1224
76. Kelly B, Melhem M, Zhang J et al. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant 2006; 21: 2425-2431
77. McAllister TN, Maruszewski M, Garrido SA et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-1446
78. Dahl SL, Kypson AP, Lawson JH et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011; 3: 68ra9
79. Peck MK, Dusserre N, Zagalski K et al. New biological solutions for hemodialysis access. J Vasc Access 2011; 12: 185-192
80. Wu W, Allen RA, Wang Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med 2012; 18: 1148-1153